SMARCD2 and neuroblastoma: However, in the presence of 100 nM (Figure 5C, middle panel) and 1000 nM (Figure 5C, right panel) sGD2, the binding of NAXI to neuroblastoma cells was significantly reduced at all antibody concentrations compared to DB (Figure 5C).